API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/priothera-cleared-to-begin-japanese-arm-of-pivotal-phase-3-study-with-mocravimod-in-patients-with-acute-myeloid-leukemia-undergoing-allogeneic-hematopoietic-cell-transplant/
https://www.prnewswire.com/news-releases/priothera-announces-first-patients-enrolled-in-pivotal-mo-trans-global-phase-2b3-study-with-mocravimod-as-an-adjunctive-and-maintenance-therapy-for-patients-with-acute-myeloid-leukemia-aml-undergoing-allogeneic-hematopoietic-ce-301727867.html
https://www.prnewswire.com/news-releases/priothera--fda-and-ema-grant-orphan-drug-designation-to-mocravimod-for-the-treatment-of-acute-myeloid-leukemia-aml-in-patients-undergoing-allogeneic-hematopoietic-stem-cell-transplantation-hsct-301494655.html